US Patent Family Members and Approved Drugs for Canada Patent: 2228389
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2228389
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2041-03-08 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
